Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Classifica tra le azioni #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Prezzo delle azioni
$4.84
Capitalizzazione di mercato
$633.18M
Variazione (1 giorno)
3.20%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Exscientia plc (EXAI)

Categoria

Healthcare
Rapporto P/S per Exscientia plc (EXAI)
Rapporto P/S al April 2026 TTM: 23.78
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Exscientia plc, il rapporto P/S attuale (TTM) è 23.78. Alla fine del 2022, era pari a 24.27.
Storico del rapporto P/S per Exscientia plc da 2019 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 23.78 -23.72%
2023 31.18 28.46%
2022 24.27 -72.05%
2021 86.85 -52.06%
2020 181.16 -12.07%
2019 206.03 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.32 -86.04%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.42 -60.38%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.60 -76.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.36 -73.27%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -87.22%
AU